Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer

Summary

For this study, high risk prostate cancer patients with lower risk ARTERA scores will be treated with 6 months of Androgen Deprivation Therapy (ADT) in conjunction with dose escalated radiotherapy to the prostate and nodes. Specifically, patients enrolled in this study will undergo one of several dose-escalated forms of radiotherapy which would include SBRT with or without a brachytherapy boost.

Timeline

Start

2026-08-06

Primary completion

2028-08-01

Completion

2029-08-01

Drugs

Indications